Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

0Tip RSCInsights

Authors

David Franz•Tarek Sahmoud21 more•Sergiusz Jóźwiak

Journal

The Lancet

Published

November 14, 2012

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Oncology

Pathology

Physiology

Medicine

Internal Medicine

Show all topics

DOI

10.1016/s0140-6736(12)61134-9

License

Unknown License